Product Code: GVR-4-68040-562-5
DNA Nanotechnology Market Growth & Trends:
The global DNA nanotechnology market size is expected to reach USD 13.21 billion by 2030 and is anticipated to grow at a CAGR of 19.89% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth is driven by rising demand for targeted drug delivery, advanced diagnostics, AI integration in nanostructure design, and increased R&D investments in healthcare and biotechnology sectors.
Furthermore, DNA nanostructures enable precise delivery of therapeutics, reducing side effects and improving treatment outcomes. This precision is especially valuable in oncology, where targeted delivery can minimize damage to healthy cells. In addition, these nanostructures offer programmability and biocompatibility, making them ideal carriers for a wide range of drugs and genetic materials. DNA nanotechnology is crucial in developing patient-specific therapies as personalized medicine gains traction. These innovations are accelerating the adoption of DNA nanostructures in modern drug delivery systems and broader biomedical applications, combined with advancements in AI and nanofabrication.
The COVID-19 pandemic further accelerated the demand for DNA nanotechnology owing to its potential in rapid diagnostics, vaccine development, and targeted drug delivery. DNA-based nanostructures were explored for their ability to detect viral RNA with high sensitivity and support the design of novel therapeutic platforms. The urgent need for advanced biomedical tools during the pandemic highlighted the versatility and scalability of DNA nanotech, driving increased investment and research in the field.
In addition, AI is enhancing the design and efficiency of DNA nanodevices by accelerating structural predictions, optimizing assembly pathways, and improving functional accuracy. Machine learning algorithms enable rapid simulation and analysis, reducing development time and costs. This integration of AI supports the creation of more stable, complex, and application-specific nanostructures, further expanding the potential of DNA nanotechnology in medicine, diagnostics, and nanomaterials.
However, designing and synthesizing DNA nanostructures remains expensive and resource-intensive, which is anticipated to hamper market growth. This is attributed to the need for specialized equipment, skilled expertise, and time-consuming validation processes. These factors increase production costs and limit scalability, posing challenges for widespread adoption. Addressing these limitations will be critical for sustaining long-term market expansion.
DNA Nanotechnology Market Report Highlights:
- The structural DNA nanotechnology segment dominated the market in 2024, driven by the increasing demand for precise, programmable, and stable nanostructures used in drug delivery, diagnostics, and material sciences.
- The diagnostics and biosensing development segment is projected to grow at the fastest CAGR of 20.95% over the forecast period, fueled by the growing need for highly sensitive, rapid, and accurate molecular detection systems for early disease diagnosis and personalized medicine.
- The biotechnology and pharmaceuticals segment is projected to grow at the fastest CAGR over the forecast period, driven by increased investment in nanotechnology R&D, in-house manufacturing capabilities, and strategic partnerships to accelerate therapy development.
- North America dominated the global market due to its well-established regulatory frameworks and healthcare infrastructure, facilitating the clinical translation and adoption of DNA nanotechnology-based products, further propelling market growth.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Technology
- 1.2.2. Application
- 1.2.3. End Use
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. DNA Nanotechnology Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rising Applications in Drug Delivery and Cancer Therapeutics
- 3.2.1.2. Advancements in DNA Origami & Self-Assembly Techniques
- 3.2.2. Market restraint analysis
- 3.2.2.1. High Cost and Complexity of Manufacturing
- 3.3. DNA Nanotechnology Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. DNA Nanotechnology Market: Technology Estimates & Trend Analysis
- 4.1. Technology Segment Dashboard
- 4.2. Global DNA Nanotechnology Market Technology Movement Analysis
- 4.3. Global DNA Nanotechnology Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
- 4.4. Dynamic DNA Nanotechnology
- 4.4.1. Dynamic DNA Nanotechnology Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
- 4.4.2. Extended Lattices
- 4.4.2.1. Extended Lattices Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.4.3. Discrete Structures
- 4.4.3.1. Discrete Structures Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.4.4. Template Assembly
- 4.4.4.1. Template Assembly Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.4.5. Others
- 4.4.5.1. Others Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.5. Structural DNA Nanotechnology
- 4.5.1. Structural DNA Nanotechnology Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
- 4.5.2. Nanomechanical Devices
- 4.5.2.1. Nanomechanical Devices Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.5.3. Strand Displacement Cascades
- 4.5.3.1. Strand Displacement Cascades Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.5.4. Others
- 4.5.4.1. Others Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. DNA Nanotechnology Market: Application Estimates & Trend Analysis
- 5.1. Application Segment Dashboard
- 5.2. Global DNA Nanotechnology Market Application Movement Analysis
- 5.3. Global DNA Nanotechnology Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Drug Delivery Systems
- 5.4.1. Drug Delivery Systems Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
- 5.5. Diagnostics and Biosensing Development
- 5.5.1. Diagnostics and Biosensing Development Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
- 5.6. Material Science and Nanoassembly
- 5.6.1. Material Science and Nanoassembly Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
- 5.7. Others
- 5.7.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
Chapter 6. DNA Nanotechnology Market: End Use Estimates & Trend Analysis
- 6.1. End Use Segment Dashboard
- 6.2. Global DNA Nanotechnology Market End Use Movement Analysis
- 6.3. Global DNA Nanotechnology Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 6.4. Academic & Research Institutions
- 6.4.1. Academic & Research Institutions Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
- 6.5. Biotechnology and Pharmaceuticals
- 6.5.1. Biotechnology and Pharmaceuticals Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
- 6.6. Other
- 6.6.1. Other Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
Chapter 7. DNA nanotechnology market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2024 & 2030
- 7.2. Regional Market Dashboard
- 7.3. North America
- 7.3.1. U.S.
- 7.3.1.1. Key country dynamics
- 7.3.1.2. Regulatory framework
- 7.3.1.3. Competitive scenario
- 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.2. Canada
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Regulatory framework
- 7.3.2.3. Competitive scenario
- 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.3. Mexico
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Regulatory framework
- 7.3.3.3. Competitive scenario
- 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4. Europe
- 7.4.1. UK
- 7.4.1.1. Key country dynamics
- 7.4.1.2. Regulatory framework
- 7.4.1.3. Competitive scenario
- 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.2. Germany
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Regulatory framework
- 7.4.2.3. Competitive scenario
- 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.3. France
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Regulatory framework
- 7.4.3.3. Competitive scenario
- 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.4. Italy
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Regulatory framework
- 7.4.4.3. Competitive scenario
- 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.5. Spain
- 7.4.5.1. Key country dynamics
- 7.4.5.2. Regulatory framework
- 7.4.5.3. Competitive scenario
- 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.6. Norway
- 7.4.6.1. Key country dynamics
- 7.4.6.2. Regulatory framework
- 7.4.6.3. Competitive scenario
- 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.7. Sweden
- 7.4.7.1. Key country dynamics
- 7.4.7.2. Regulatory framework
- 7.4.7.3. Competitive scenario
- 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.8. Denmark
- 7.4.8.1. Key country dynamics
- 7.4.8.2. Regulatory framework
- 7.4.8.3. Competitive scenario
- 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Japan
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Regulatory framework
- 7.5.1.3. Competitive scenario
- 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. China
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework
- 7.5.2.3. Competitive scenario
- 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. India
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework
- 7.5.3.3. Competitive scenario
- 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.4. Australia
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Regulatory framework
- 7.5.4.3. Competitive scenario
- 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.5. South Korea
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Regulatory framework
- 7.5.5.3. Competitive scenario
- 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.6. Thailand
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Regulatory framework
- 7.5.6.3. Competitive scenario
- 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6. Latin America
- 7.6.1. Brazil
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Regulatory framework
- 7.6.1.3. Competitive scenario
- 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.2. Argentina
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework
- 7.6.2.3. Competitive scenario
- 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7. MEA
- 7.7.1. South Africa
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Regulatory framework
- 7.7.1.3. Competitive scenario
- 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.2. Saudi Arabia
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework
- 7.7.2.3. Competitive scenario
- 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. UAE
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Regulatory framework
- 7.7.3.3. Competitive scenario
- 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.4. Kuwait
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Regulatory framework
- 7.7.4.3. Competitive scenario
- 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Participant Categorization
- 8.2. Company Market Position Analysis, 2024
- 8.3. Strategy Mapping
- 8.4. Participants Overview
- 8.4.1. Gattaquant
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Product benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. Nanobio Designs
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Product benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. Tilibit
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Product benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. Helixworks
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Product benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. SomaLogic
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Product benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. EnaChip
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Product benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. Ginkgo Bioworks
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Product benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. Nanolab Technologies
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Product benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. Nanogami
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Product benchmarking
- 8.4.9.4. Strategic initiatives
- 8.4.10. DNA Nanobots, LLC
- 8.4.10.1. Company overview
- 8.4.10.2. Financial performance
- 8.4.10.3. Product benchmarking
- 8.4.10.4. Strategic initiatives